The Association of Cancer Physicians Breast Cancer Forum: implications of Calman-Hine for breast cancer services.
Leonard
R C
RC
Department of Clinical Oncology, Western General Hospital, Edinburgh, UK.
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000000981:diagnostic imaging / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy*; D002173:Cancer Care Facilities / Q000706:statistics & numerical data; D019090:Case Management / Q000592:standards*; D003625:Data Collection; D003695:Delivery of Health Care / Q000592:standards*; D005260:Female; D013502:General Surgery; D006801:Humans; D008327:Mammography / Q000592:standards; D008403:Mass Screening / Q000458:organization & administration / Q000592:standards; D008408:Mastectomy; D008495:Medical Oncology; D009313:National Health Programs / Q000458:organization & administration*; D010348:Patient Care Team; D010819:Physician's Role; D017410:Practice Guidelines as Topic; D011320:Primary Health Care; D011871:Radiology; D012955:Societies, Medical; D016896:Treatment Outcome; D006113:United Kingdom; D000078329:Workforce
D018931:Antineoplastic Agents, Hormonal